The absence of orthostatic heart rate increase is associated with cognitive impairment in Parkinson's disease

被引:9
|
作者
Tanaka, Ryota [1 ,2 ]
Yamashiro, Kazuo [3 ]
Ogawa, Takashi [2 ]
Oyama, Genko [2 ]
Nishioka, Kenya [2 ]
Umemura, Atsushi [4 ]
Shimo, Yasushi [5 ]
Hattori, Nobutaka [2 ]
机构
[1] Jichi Med Univ, Div Neurol, Dept Med, Stroke Ctr,Jichi Med Univ Hosp, Shimotsuke, Tochigi, Japan
[2] Juntendo Univ, Dept Neurol, Tokyo, Japan
[3] Juntendo Univ, Dept Neurol, Urayasu Hosp, Chiba, Japan
[4] Juntendo Univ, Dept Neurosurg, Tokyo, Japan
[5] Juntendo Univ, Dept Neurol, Nerima Hosp, Tokyo, Japan
来源
PLOS ONE | 2020年 / 15卷 / 10期
关键词
CEREBRAL MICROBLEEDS; DEMENTIA; HYPOTENSION; PREVALENCE; DIAGNOSIS; SURVIVAL; FALLS; SYNUCLEINOPATHIES; ABNORMALITIES; DYSFUNCTION;
D O I
10.1371/journal.pone.0240491
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Orthostatic hypotension (OH) frequently accompanies autonomic dysfunction and is an important risk factor for cognitive impairment in Parkinson's disease (PD). While OH is usually diagnosed based on an orthostatic blood pressure drop, the association between the heart rate response and cognitive impairment remains unclear. We retrospectively analyzed 143 cases of clinically diagnosed PD to determine the association between the absence of a heart rate response and cognitive impairment in PD with OH. Among the patients with OH, neurogenic OH was diagnosed in cases without a heart rate increase, while all other patients were diagnosed with non-neurogenic OH. Dementia was found in 23 of 143 PD cases (16.1%) in this cohort. The presence of OH was an independent risk factor for dementia in PD in addition to the disease severity, years of education and beta-blockers use. Neurogenic OH was significantly associated with dementia compared to the no OH group (hazard ratio [HR] 7.3, 95% confidence interval [CI] 2.2-24.6, P<0.01), an association that was preserved after adjusting for age, gender and other covariant factors. However, no such association was observed for non-neurogenic OH (HR 2.9, 95%CI 0.8-10.9, P = 0.12). While the cognitive impairment was significantly worse in the neurogenic OH group than the no-OH group, the groups were otherwise similar. The blood pressure decrease was significantly lower in both OH groups than in the no-OH group, despite no significant differences between the OH groups. Our finding showed that OH without a heart rate response was an important predictor of cognitive impairment in PD.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Cortical Thinning Associated With Mild Cognitive Impairment in Parkinson's Disease
    Segura, Barbara
    Cesar Baggio, Hugo
    Josep Marti, Maria
    Valldeoriola, Francesc
    Compta, Yaroslau
    Isabel Garcia-Diaz, Anna
    Vendrell, Pere
    Bargallo, Nuria
    Tolosa, Eduardo
    Junque, Carme
    MOVEMENT DISORDERS, 2014, 29 (12) : 1495 - 1503
  • [42] Cerebrospinal fluid biomarkers in Parkinson's disease and associated cognitive impairment
    Delgado-Alvarado, M.
    Gago, B.
    Gorostidi, A.
    Jimenez-Urbieta, H.
    Ruiz-Martinez, J.
    Bergaretxe-Yarza, A.
    Marti-Masso, J. F.
    Martinez-Lage, P.
    Izagirre, A.
    Oregi, A.
    Sepulveda, L.
    Rodriguez-Oroz, M. C.
    MOVEMENT DISORDERS, 2016, 31 : S453 - S454
  • [43] Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease
    Tang, Yilin
    Ge, Jingjie
    Liu, Fengtao
    Wu, Ping
    Guo, Sisi
    Liu, Zhenyang
    Wang, Yixuan
    Wang, Ying
    Ding, Zhengtong
    Wu, Jianjun
    Zuo, Chuantao
    Wang, Jian
    PLOS ONE, 2016, 11 (04):
  • [44] Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
    Melzer, Tracy R.
    Stark, Megan R.
    Keenan, Ross J.
    Myall, Daniel J.
    MacAskill, Michael R.
    Pitcher, Toni L.
    Livingston, Leslie
    Grenfell, Sophie
    Horne, Kyla-Louise
    Young, Bob N.
    Pascoe, Maddie J.
    Almuqbel, Mustafa M.
    Wang, Jian
    Marsh, Steven H.
    Miller, David H.
    Dalrymple-Alford, John C.
    Anderson, Tim J.
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [45] Cortical thinning associated with mild cognitive impairment in Parkinson's disease
    Galantucci, S.
    Agosta, F.
    Stojkovic, T.
    Petrovic, I.
    Stefanova, E.
    Canu, E.
    Copetti, M.
    Kostic, V. S.
    Filippi, M.
    MOVEMENT DISORDERS, 2016, 31 : S417 - S417
  • [46] Acoustic prosodic parameters associated with Parkinson's disease cognitive impairment
    Liu, Ye
    Wang, Xi-Xi
    Wang, Xu-Jun
    Yin, Min-Min
    Tan, Mo-Yao
    Wang, Chang-Peng
    Feng, Tie-Nan
    Liu, Jie
    Wang, Yu
    Li, Xuan
    Peng, Si-Jia
    Zhang, Xiao-Jin
    Zhu, Xiao-Ying
    Feng, Ya
    Tan, Eng-King
    Wu, Yun-Cheng
    PARKINSONISM & RELATED DISORDERS, 2025, 132
  • [47] The pattern of cognitive impairment associated with the motor subtype in Parkinson's disease
    Park, I. S.
    JOURNAL OF NEUROLOGY, 2009, 256 : S225 - S225
  • [48] The presence of cerebral microbleeds is associated with cognitive impairment in Parkinson's disease
    Daida, Kensuke
    Tanaka, Ryota
    Yamashiro, Kazuo
    Ogawa, Takashi
    Oyama, Genko
    Nishioka, Kenya
    Shimo, Yasushi
    Umemura, Atsushi
    Hattori, Nobutaka
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 393 : 39 - 44
  • [49] Gut microbiome is not associated with mild cognitive impairment in Parkinson's disease
    Aho, Velma T. E.
    Klee, Matthias
    Landoulsi, Zied
    Heintz-Buschart, Anna
    Pavelka, Lukas
    Leist, Anja K.
    Krueger, Rejko
    May, Patrick
    Wilmes, Paul
    NPJ PARKINSONS DISEASE, 2024, 10 (01)
  • [50] Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease
    Velma T. E. Aho
    Matthias Klee
    Zied Landoulsi
    Anna Heintz-Buschart
    Lukas Pavelka
    Anja K. Leist
    Rejko Krüger
    Patrick May
    Paul Wilmes
    npj Parkinson's Disease, 10